115
Participants
Start Date
October 10, 2025
Primary Completion Date
November 26, 2028
Study Completion Date
January 31, 2029
Metformin
1000 mg metformin-HCL XR once-a-day or maintenance dose of metformin for 26 weeks
Val, Cel and Met XR Low
500 mg metformin-HCL XR plus 100 mg celecoxib once-a-day in the morning and 160 mg valsartan 6 hours later once-a-day in the afternoon for 26 weeks.
Val, Cel and Met XR High
1000 mg metformin-HCL XR plus 200 mg celecoxib once-a-day in the morning and 320 mg valsartan once-a-day 6 hours later in the afternoon for 26 weeks.
Albany Medical College, Albany
Lead Sponsor
Collaborators (1)
Albany Medical College
OTHER
Myopharm Limited
OTHER
ARKAY Therapeutics
INDUSTRY